{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:36:54Z","timestamp":1792651014508,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006369","name":"George Mason University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006369","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.crmeth.2022.100181","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:32:23Z","timestamp":1645662743000},"page":"100181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs"],"prefix":"10.1016","volume":"2","author":[{"given":"Brian","family":"Hetrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda D.","family":"Chilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deemah","family":"Dabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhang","family":"Alem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuanjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshaka","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel F.","family":"Petricoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Andalibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2022.100181_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crmeth.2022.100181_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.crmeth.2022.100181_bib3","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100181_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.crmeth.2022.100181_bib5","first-page":"237","article-title":"The SFV gene expression system","volume":"13","author":"Ciccarone","year":"1998","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.crmeth.2022.100181_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100181_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.crmeth.2022.100181_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrmicro3490","article-title":"HIV-1 assembly, release and maturation","volume":"13","author":"Freed","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmeth.2022.100181_bib9","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1073\/pnas.1916054117","article-title":"PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cells","volume":"117","author":"Fu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.crmeth.2022.100181_bib10","first-page":"536","article-title":"Coronaviridae study group of the international committee on taxonomy of viruses","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2022.100181_bib11","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1073\/pnas.89.7.2679","article-title":"Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation","volume":"89","author":"Hahn","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.crmeth.2022.100181_bib12","first-page":"46","article-title":"PSGL-1 inhibits the incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins into pseudovirions and impairs","volume":"13","author":"He","year":"2021","journal-title":"Pseudovirus Attachment and Infectivity Viruses"},{"key":"10.1016\/j.crmeth.2022.100181_bib13","doi-asserted-by":"crossref","first-page":"103255","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity","volume":"65","author":"Hoffmann","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.crmeth.2022.100181_bib14","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1128\/JVI.79.22.13848-13855.2005","article-title":"Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent","volume":"79","author":"Hsieh","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100181_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.crmeth.2022.100181_bib16","doi-asserted-by":"crossref","first-page":"14031","DOI":"10.1038\/s41598-020-70827-z","article-title":"Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide","volume":"10","author":"Isabel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmeth.2022.100181_bib17","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crmeth.2022.100181_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.virol.2007.11.007","article-title":"Human macrophages support persistent transcription from unintegrated HIV-1 DNA","volume":"372","author":"Kelly","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.crmeth.2022.100181_bib19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2022.100181_bib20","doi-asserted-by":"crossref","first-page":"e1963","DOI":"10.1002\/rmv.1963","article-title":"Current status on the development of pseudoviruses for enveloped viruses","volume":"28","author":"Li","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.crmeth.2022.100181_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100181_bib22","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nbt1291-1356","article-title":"A new generation of animal cell expression vectors based on the Semliki Forest virus replicon","volume":"9","author":"Liljestr\u00f6m","year":"1991","journal-title":"Biotechnology (N Y)"},{"key":"10.1016\/j.crmeth.2022.100181_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41564-019-0372-2","article-title":"Proteomic profiling of HIV-1 infection of human CD4(+) T\u00a0cells identifies PSGL-1 as an HIV restriction factor","volume":"4","author":"Liu","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2022.100181_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41467-020-20768-y","article-title":"The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein","volume":"12","author":"Lu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2022.100181_bib25","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1073\/pnas.1916055117","article-title":"Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding","volume":"117","author":"Murakami","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.crmeth.2022.100181_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.crmeth.2022.100181_bib27","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay","volume":"15","author":"Nie","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.crmeth.2022.100181_bib28","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2022.100181_bib29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.crmeth.2022.100181_bib30","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1099\/vir.0.80111-0","article-title":"Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine","volume":"85","author":"Pang","year":"2004","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.crmeth.2022.100181_bib31","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crmeth.2022.100181_bib32","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.crmeth.2022.100181_bib33","author":"Rambaut"},{"key":"10.1016\/j.crmeth.2022.100181_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100181_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0092-8674(94)90258-5","article-title":"Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA","volume":"79","author":"Rolls","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2022.100181_bib36","doi-asserted-by":"crossref","first-page":"16866","DOI":"10.1073\/pnas.1414991111","article-title":"In\u00a0vitro evolution of high-titer, virus-like vesicles containing a single structural protein","volume":"111","author":"Rose","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.crmeth.2022.100181_bib37","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1073\/pnas.0800280105","article-title":"Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors","volume":"105","author":"Rose","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.crmeth.2022.100181_bib38","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/JVI.00342-11","article-title":"Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen","volume":"85","author":"Schell","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100181_bib39","doi-asserted-by":"crossref","first-page":"e20201181","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.crmeth.2022.100181_bib40","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.molimm.2005.11.005","article-title":"The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization","volume":"43","author":"Shi","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.crmeth.2022.100181_bib41","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1128\/JVI.01052-08","article-title":"The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles","volume":"82","author":"Siu","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100181_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.20411\/pai.v5i1.377","article-title":"The structure of the membrane protein of SARS-CoV-2 resembles the sugar transporter SemiSWEET","volume":"5","author":"Thomas","year":"2020","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.crmeth.2022.100181_bib43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/jcb.24468","article-title":"Anti-adhesive property of P-selectin glycoprotein ligand-1 (PSGL-1) due to steric hindrance effect","volume":"114","author":"Umeki","year":"2013","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.crmeth.2022.100181_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmeth.2022.100181_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.crmeth.2022.100181_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2022.100181_bib47","series-title":"The Togaviruses","first-page":"459","article-title":"16 - effects of alphaviruses on host cell macromolecular synthesis","author":"Wengler","year":"1980"},{"key":"10.1016\/j.crmeth.2022.100181_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.crmeth.2022.100181_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2019.09.115","article-title":"An in\u00a0vivo cell-based assay for investigating the specific interaction between the SARS-CoV N-protein and its viral RNA packaging sequence","volume":"520","author":"Woo","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.crmeth.2022.100181_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100181_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(20)30557-2","article-title":"SARS-CoV-2 is an appropriate name for the new coronavirus","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.crmeth.2022.100181_bib52","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.2922607","article-title":"Sindbis virus: an efficient, broad host range vector for gene expression in animal cells","volume":"243","author":"Xiong","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100181_bib53","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fbioe.2020.00862","article-title":"Construction of SARS-CoV-2 virus-like particles by mammalian expression system","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.crmeth.2022.100181_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bsheal.2020.08.004","article-title":"Development and effectiveness of Pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in\u00a0vitro","volume":"2","author":"Yang","year":"2020","journal-title":"Biosaf. Health"},{"key":"10.1016\/j.crmeth.2022.100181_bib55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.isci.2019.10.040","article-title":"Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B","volume":"21","author":"Yarovinsky","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.crmeth.2022.100181_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.crmeth.2022.100181_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41392-020-00372-8","article-title":"A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.crmeth.2022.100181_bib58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100181_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237522000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237522000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:57:08Z","timestamp":1762642628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237522000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2667237522000364"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2022.100181","relation":{},"ISSN":["2667-2375"],"issn-type":[{"value":"2667-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2022.100181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100181"}}